Bempedoic acid
Esperion
[]
big article on nexletol in nejm and presented today at acc conference. 14,000 patient study shows 23% drop in heart attack compared to placebo. also dropped hscrp significantly 
Bruce K. Patterson MD, CEO IncellDx, Previously Assoc Prof Stanford School of Medicine